On valuing morbidity, cost-effectiveness analysis, and being rude

Journal of Health Economics

Volumn 16, Issue 6, 1997, Pages 749-757

  Kenkel, Don ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Cost benefit analysis; Cost effectiveness analysis; Morbidity

Indexed keywords

CONSUMER; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH SERVICES RESEARCH; HUMAN; METHODOLOGY; MORBIDITY; REVIEW; SOCIOECONOMICS; TREATMENT OUTCOME;

CONSUMER SATISFACTION; COST-BENEFIT ANALYSIS; HEALTH SERVICES RESEARCH; HUMANS; MORBIDITY; TREATMENT OUTCOME; VALUE OF LIFE;

EID: 0031300365     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0167-6296(97)00027-1     Document Type: Article

References (33)

1. Agee, M.D., Crocker, T.D., 1996. Parental altruism and child lead exposure: inference from the demand for chelation therapy. J. Hum. Resour. 31, 677-691.
2. Boardman, A.E., Greenberg, D.H., Vining, A.R., Weimer, D.L., 1996. Cost-Benefit Analysis: Concepts and Practice. Prentice-Hall, Upper Saddle River, NJ.
3. Dickie, M., Gerking, S., 1991. Valuing reduced morbidity: a household production approach. South. Econ. J. 57, 280-292.
4. Evans, W.N., Viscusi, W.K., 1993, Income effects and the value of health. J. Hum. Resour. 28, 497-518.
5. Garber, A.M., Phelps, C.E., 1997. Economic foundations of cost-effectiveness analysis. J. Health Econ. 16, 1-31.
6. Garber, A.M., Weinstein, M.C., Torrance, G.W., Kamlet, M.S., 1996. Theoretical foundations of cost-effectiveness analysis. In: Gold, M.R., Siegel, J.E., Russell, L.B., Weinstein, M.C. (Eds.), Cost-Effectiveness in Health and Medicine. Oxford Univ. Press, New York, pp. 25-53.
7. Gerking, S., Stanley, L., 1986. An economic analysis of air pollution and health: the case of St. Louis. Rev. Econ. Stat. 68, 115-121.
8. Gold, M.R., Siegel, J.E., Russell, L.B., Weinstein, M.C. (Eds.), 1996. Cost-Effectiveness in Health and Medicine. Oxford Univ. Press, New York.
9. Harberger, A.C., 1983. Basic needs versus distributional weights in social cost-benefit analysis. In: Haveman, R.H., Margolis, J. (Eds.), Public Expenditure and Policy Analysis, 3rd edn. Houghton Mifflin, Boston, pp. 105-126.
10. Johannesson, M., Johansson, P.-O., Kristom, B., Borquist, L., Jonsson, B., 1993a. Willingness to pay for lipid lowering: a health production function approach. Appl. Econ. 25, 1023-1031.
11. Johannesson, M., Johansson, P.-O., Kristom, B., Gerdtham, U.-G., 1993b. Willingness to pay for antihypertensive therapy: further results. J. Health Econ. 12, 95-108.
12. Johannesson, M., Jonsson, B., Borquist, L., 1991. Willingness to pay for antihypertensive therapy: results of a Swedish pilot study. J. Health Econ. 10, 461-474.
13. Johannesson, M., Jonsson, B., Karlsson, G., 1996. Outcome measurement in economic evaluation. Health Econ. 5, 279-296.
14. Johnson, F.R., Fries, E.E., Banzhaf, H.S., 1997. Valuing morbidity: an integration of the willingness-to-pay and health-status index literatures, J. Health Econ.
15. Kelly, A.B., Haddix, A.C., Scanlon, K.S., Helmick, C.G., Mulinare, H., 1996. Cost-effectiveness of strategies to prevent neural tube defects. In: Gold, M.R., Siegel, J.E.. Russell, L.B., Weinstein, M.C. (Eds.), Cost-Effectiveness in Health and Medicine. Oxford Univ. Press, New York, pp. 313-348.
16. Kenkel, D.S., 1994. Cost of illness approach. In: Tolley, G.S., Kenkel, D.S., Fabian, R. (Eds.), Valuing Health for Policy: an Economic Approach. University of Chicago Press, Chicago, pp. 42-71.
17. Krupnick, A.J., Cropper, M., 1992. The effect of information on health risk valuation. J. Risk Uncertainty 5, 29-48.
18. Meltzer, D., 1997. Accounting for future costs in medical cost-effectiveness analysis. J. Health Econ. 16, 33-64.
19. Mishan, E.J., 1988. Cost-Benefit Analysis: an Informal Introduction. Unwin Hyman, London.
20. Neumann, P.J., Johannesson, M., 1994. The willingness to pay for in vitro fertilization: a pilot study using contingent valuation. Med. Care 32, 686-699.
21. O'Conor, R.M., Blomquist, G.C., forthcoming. Measurement of consumer-patient preferences using a hybrid contingent valuation method. J. Health Econ.
22. Pauly, M.V., 1995. Valuing health benefits in money terms. In: Sloan, F.A. (Ed.), Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and other Medical Technologies. Cambridge Univ. Press, Cambridge, UK, pp. 99-124.
23. Phelps, C.E., Mushlin, A.I., 1991. On the near equivalence of cost effectiveness and cost benefit analysis. Int. J. Tech. Assessment Health Care 7, 12-21.
24. Russell, L.B., Siegel, J.E., Daniels, N., Gold, M.R., Luce, B.R., Mandelblatt, J.S., 1996. Cost-effectiveness analysis as a guide to resource allocation in health: roles and limitations. In: Gold, M.R., Siegel, J.E., Russell, L.B., Weinstein, M.C. (Eds.), Cost-Effectiveness in Health and Medicine. Oxford Univ. Press, New York, pp. 3-24.
25. Sloan, F.A. (Ed.), 1995. Valuing health care: Costs, benefits, and effectiveness of pharmaceuticals and other medical technologies. Cambridge Univ. Press, Cambridge, UK.
26. Sloan, F.A., Conover, C.J., 1995, The use of cost-effectiveness/cost-benefit analysis in actual decision making: current status and prospects. In: Sloan, F.A. (Ed.), Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and other Medical Technologies. Cambridge Univ. Press, Cambridge, UK, pp. 207-232.
27. Thompson, M.S., Read, J.L., Liang, M., 1984. Feasibility of willingness-to-pay measurement in chronic arthritis. Med. Decis. Mak. 4, 195-215.
28. Tolley, G.S., Kenkel, D.S., Fabian, R., 1994. State-of-the-art health values. In: Tolley, G.S., Kenkel, D.S., Fabian, R. (Eds.), Valuing Health for Policy: an Economic Approach. University of Chicago Press, Chicago, pp. 323-344.
29. Viscusi, W.K., 1993. The value of risks to life and health. J. Econ. Lit. 31, 1912-1946.
30. Viscusi, W.K., 1996. Economic foundations of the current regulatory reform efforts. J. Econ. Perspect. 10, 119-134.
31. Viscusi, W.K., Magat, W.A., Huber, J., 1991. Pricing environmental health risks: survey assessments of risk-risk and risk-dollar tradeoffs for chronic bronchitis. J. Environ. Econ. Manage. 21, 32-51.
32. Washerman, J., Manning, W.G., Newhouse, J.P., Winkler, J.D., 1991. The effects of excise taxes and regulation on cigarette smoking. J. Health Econ. 10, 43-64.
33. Willig, R.D., 1976. Consumer's surplus without apology. Am. Econ. Rev. 66, 589-597.